We are live on
!
Find out more
Rocket Pharmaceuticals Warrant
RCKTW
RCKTW
16 hedge funds and large institutions have $5.39M invested in Rocket Pharmaceuticals Warrant in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,165% more capital invested
Capital invested by funds: $426K → $5.39M (+$4.96M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7% more funds holding
Funds holding: 15 → 16 (+1)
0.12% more ownership
Funds ownership: 4.01% → 4.13% (+0.12%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BFM
Boothbay Fund Management
New York
|
+$44K |
| 2 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
+$37.2K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$11.1K |
| 4 |
PVI
Pura Vida Investments
New York
|
+$7.87K |
| 5 |
CS
Clear Street
New York
|
+$18 |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$60K |
| 2 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$2.43K |
| 3 |
HF
HRT Financial
New York
|
-$1.63K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$849 |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$754 |
